News

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent years, hailed as revolutionary treatments for type 2 diabetes and obesity.
NEWS Health Expert Dr. Payal Kohli talks about the new drug that Eli Lilly says can lower blood sugar levels and induce ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Michael See, MS, CDCES, ACSM-CEP, NBC-HWC, about tips for exercise for people living with diabetes. Weiner: ...
Dr. Katherine Saunders, at Weill Cornell Medicine, joined ABC News' to discuss a new daily weight loss pill by Eli Lilly ...